Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the Liver
NCT07364474
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Uveal Melanoma
Interventions
DRUG:
Melphalan through Percutaneous Hepatic Perfusion
Sponsor
Massachusetts General Hospital